Diabetes, Vol 43, Issue 5 661-666, Copyright © 1994 by American Diabetes Association
Pancreas transplantation in diabetic humans normalizes hepatic glucose production during hypoglycemia
Z Barrou, ER Seaquist and RP Robertson
Department of Medicine, University of Minnesota Medical School, Minneapolis.
Although successful pancreas transplantation in humans with type I diabetes
mellitus restores glucose-induced insulin secretion, provides freedom from
insulin treatment, and normalizes fasting glucose levels, much less is
known about its effects on counterregulation of hypoglycemia. To determine
whether pancreas transplantation normalizes glucagon secretion and hepatic
glucose production (HGP) during hypoglycemia, we performed hyperinsulinemic
hypoglycemic clamps in successful recipients of pancreas allografts.
Recipients were found to have glucagon secretory responses during
hypoglycemia that were similar to those of control subjects (incremental
glucagon response: recipients, 147 +/- 34 ng/L; control subjects, 161 +/-
43 ng/L, NS) but were significantly higher than those of matched subjects
with type I diabetes (23 +/- 9 ng/L, P < 0.01). HGP rates at the end of
120 min of hypoglycemia were also significantly higher in recipients and
control subjects than in subjects with diabetes (pancreas recipients, 1.92
+/- 0.33 mg.kg-1.min-1; control subjects, 2.05 +/- 0.18 mg.kg-1.min-1;
subjects with type I diabetes, 0.58 +/- 0.12 mg.kg-1.min-1). A comparison
with a third group of nondiabetic kidney transplant recipients demonstrated
that the beneficial effects on glucose counterregulation were a result of
pancreas transplantation and not the associated immunosuppressive therapy.
We conclude that pancreas transplantation restores hypoglycemia-induced
glucagon secretion and HGP, thereby allowing for normalization of glucose
recovery from hypoglycemia.